A womans risk of ovarian cancer rises significantly if she carries either of two previously unexamined variations in the gene that codes for the progesterone receptor, according to a team of researchers led by scientists from the Keck School of Medicine of the University of Southern California.
The study, which is being published in the January 5th issue of the Journal of the National Cancer Institute, was initially supposed to be a more in-depth look at one particular version-or allele-of the progesterone receptor gene (PGR). The PROGINS allele, says Celeste Leigh Pearce, a preventive medicine researcher from the USC/Norris Comprehensive Cancer Center and the papers first author, had previously been linked to a higher ovarian cancer risk as well as a lower breast cancer risk in women who carry it.
To see if the PROGINS allele did indeed confer a higher ovarian cancer risk on women, the researchers-led by the studys principal investigator, USC preventive medicine professor Malcolm Pike-first used biological samples collected by the Hawaii/Los Angeles Multiethnic Cohort Study. (The Multiethnic Cohort is one of the largest ongoing population studies in the world, and is led by Brian E. Henderson, M.D., the Kenneth T. Norris Jr. Chair in Cancer Prevention and dean of the Keck School of Medicine.) The scientists examined the variety of genetic variations found in the PGR gene as part of a long-term collaboration between USC researchers and those at the Broad Institute in Cambridge, MA, looking to ascertain if the PROGINS allele held a particular risk of ovarian cancer for women.
Jon Weiner | EurekAlert!
New 3-D imaging reveals how human cell nucleus organizes DNA and chromatin of its genome
28.07.2017 | University of California - San Diego
Malaria Already Endemic in the Mediterranean by the Roman Period
27.07.2017 | Universität Zürich
26.07.2017 | Event News
21.07.2017 | Event News
19.07.2017 | Event News
28.07.2017 | Health and Medicine
28.07.2017 | Power and Electrical Engineering
28.07.2017 | Life Sciences